GT Biopharma, Inc. (GTBP) (CIK 0000109657) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-003958
- Form
- CORRESP
- Filer
- GT Biopharma, Inc. (GTBP) (CIK 0000109657)
- CIK
- 0000109657
- Ticker
- GTBP
- Filed
- 2026-01-28
- SIC industry
- 2834
- HQ
- San Francisco, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/109657/000149315226003958/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer